Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mopidamol

Drug Profile

Mopidamol

Alternative Names: OLX 102; RA 233; Rapenton

Latest Information Update: 27 Mar 2002

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Boehringer Ingelheim Pharma KG
  • Developer Antigenics; Boehringer Ingelheim Pharma KG
  • Class Pyrimidines; Small molecules
  • Mechanism of Action Immunostimulants; Phosphoric diester hydrolase inhibitors; Thromboxane receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Cancer metastases
  • Discontinued Non-small cell lung cancer; Ovarian cancer; Thrombosis

Most Recent Events

  • 27 Mar 2002 Launched for Cancer metastases in Germany (IV)
  • 07 Feb 2001 No-Development-Reported for Cancer metastases in Germany (IV)
  • 12 Jan 2000 Discontinued-Clinical for Ovarian cancer in Finland (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top